SEC Reports
5
BRSYF
Brainsway Ltd.
$15.13 ▲ +0.00%
Prev close $15.13High Impact Filing (7/10) Healthcare & Medical Devices
Snapshot
The big-picture read on BRSYF right now — valuation, ownership and activity at a glance.
Price chart 30d +0.0%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Jun 9, 2026 SEC May 18, 2026 SEC May 13, 2026 SEC
BrainsWay presented new 12-month durability data for its SWIFT accelerated Deep TMS protocol at the CTMSS annual meeting
6-K — Impact 7/10
BrainsWay announced a minority-stake investment of $1.5 million (with potential for an additional $1.5 million via miles
6-K — Impact 4/10
BrainsWay reported Q1 2026 revenue of $15.5 million (up 35% YoY) and net income of $2.3 million (up >100% YoY), with Adj
6-K — Impact 8/10
Analyst ratings buy % +0.0%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 3 | 3 | 1 | 0 | 0 | 86% | |
| Aug 1, 2026 | 3 | 3 | 1 | 0 | 0 | 86% | |
| Jul 1, 2026 | 3 | 3 | 1 | 0 | 0 | 86% | |
| Jun 1, 2026 | 3 | 3 | 1 | 0 | 0 | 86% | |
| May 1, 2026 | 3 | 3 | 1 | 0 | 0 | 86% | |
| Apr 1, 2026 | 3 | 3 | 1 | 0 | 0 | 86% | |
| Mar 1, 2026 | 3 | 3 | 1 | 0 | 0 | 86% | |
| Feb 1, 2026 | 3 | 3 | 1 | 0 | 0 | 86% |
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
5 SEC filing reports analyzed · 4 bullish, 0 bearish, 0 mixed, 1 neutral · avg impact 6.6/10.
BULLISH6-K7/10
BrainsWay presented new 12-month durability data for its SWIFT accelerated Deep TMS protocol at the
Jun 9, 2026
NEUTRAL6-K4/10
BrainsWay announced a minority-stake investment of $1.5 million (with potential for an additional $1
May 18, 2026
BULLISH6-K8/10
BrainsWay reported Q1 2026 revenue of $15.5 million (up 35% YoY) and net income of $2.3 million (up
May 13, 2026
BULLISH20-F7/10
Brainsway's 20-F filing for 2025 shows strong financial growth with a 27% revenue increase to $52.2
Apr 20, 2026
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
| Next Q | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
| Current FY | $0.00 | $0.00–$0.00 | — | — | — | $0.1B | — |
| Next FY | $0.00 | $0.00–$0.00 | — | — | — | $0.1B | — |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for BRSYF.
Shares short
1,500
Settlement Sep 15, 2026
Change vs prior
+17.1%
Semi-monthly cycle
All BRSYF filing & press-release reports (5)
- 6-K reportJun 9, 2026
- 6-K reportMay 18, 2026
- 6-K reportMay 13, 2026
- 20-F reportApr 20, 2026
- 6-K reportApr 15, 2026